SG11201705728RA - Methods of treating inflammatory diseases - Google Patents
Methods of treating inflammatory diseasesInfo
- Publication number
- SG11201705728RA SG11201705728RA SG11201705728RA SG11201705728RA SG11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- inflammatory diseases
- treating inflammatory
- treating
- diseases
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562111731P | 2015-02-04 | 2015-02-04 | |
| US201562130876P | 2015-03-10 | 2015-03-10 | |
| US201562135335P | 2015-03-19 | 2015-03-19 | |
| US201562145764P | 2015-04-10 | 2015-04-10 | |
| US201562204520P | 2015-08-13 | 2015-08-13 | |
| US201562235631P | 2015-10-01 | 2015-10-01 | |
| PCT/US2016/016061 WO2016126638A1 (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705728RA true SG11201705728RA (en) | 2017-08-30 |
Family
ID=55453266
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705728RA SG11201705728RA (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
| SG10202103879YA SG10202103879YA (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202103879YA SG10202103879YA (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20160222102A1 (en) |
| EP (1) | EP3253794A1 (en) |
| JP (5) | JP6758304B2 (en) |
| KR (1) | KR20170120616A (en) |
| CN (2) | CN107206081A (en) |
| AU (2) | AU2016215535B2 (en) |
| BR (1) | BR112017014684A2 (en) |
| CA (1) | CA2972995A1 (en) |
| CL (1) | CL2017001960A1 (en) |
| EA (1) | EA201791734A1 (en) |
| IL (2) | IL307578A (en) |
| MX (3) | MX2017010037A (en) |
| PH (1) | PH12017501378A1 (en) |
| SG (2) | SG11201705728RA (en) |
| WO (1) | WO2016126638A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8778346B2 (en) | 2010-11-04 | 2014-07-15 | Boehringer Ingelheim International Gmbh | Anti-IL-23 antibodies |
| AU2013256724A1 (en) | 2012-05-03 | 2014-10-30 | Boehringer Ingelheim International Gmbh | Anti-IL-23p19 antibodies |
| EP3708679A1 (en) | 2014-07-24 | 2020-09-16 | Boehringer Ingelheim International GmbH | Biomarkers useful in the treatment of il-23a related diseases |
| EA202193002A2 (en) | 2014-09-03 | 2022-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | COMPOUND TARGETED TO IL-23A AND TNF-ALFA AND ITS APPLICATION |
| AU2016215535B2 (en) * | 2015-02-04 | 2021-09-16 | Boehringer Ingelheim International Gmbh | Methods of treating inflammatory diseases |
| WO2017180821A1 (en) * | 2016-04-15 | 2017-10-19 | Boehringer Ingelheim International Gmbh | Methods of treating inflammatory diseases |
| KR20190059305A (en) * | 2016-09-30 | 2019-05-30 | 얀센 바이오테크 인코포레이티드 | A safe and effective way to treat psoriasis with anti-IL23-specific antibodies |
| CN106778030B (en) * | 2017-01-10 | 2023-04-07 | 广州和康医疗技术有限公司 | Ankylosing spondylitis condition monitoring and management system and monitoring and management method thereof |
| CA3120237A1 (en) | 2018-11-20 | 2020-05-28 | Janssen Biotech, Inc. | Safe and effective method of treating psoriasis with anti-il-23 specific antibody |
| CN111378045B (en) * | 2018-12-28 | 2022-08-02 | 长春金赛药业有限责任公司 | Bivalent and bispecific antibody, preparation method thereof, encoding gene, host cell and composition |
| TW202123965A (en) * | 2019-09-09 | 2021-07-01 | 德商百靈佳殷格翰國際股份有限公司 | Anti-il-23p19 antibody formulations |
| WO2023144699A1 (en) * | 2022-01-25 | 2023-08-03 | Sun Pharmaceutical Industries Limited | Methods for treatment of subjects with plaque psoriasis of the scalp |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (en) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Process for the biotechnical production of alkaline phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| AU632065B2 (en) | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| FR2646437B1 (en) | 1989-04-28 | 1991-08-30 | Transgene Sa | NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| LU91067I2 (en) | 1991-06-14 | 2004-04-02 | Genentech Inc | Trastuzumab and its variants and immunochemical derivatives including immotoxins |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| WO1994011026A2 (en) | 1992-11-13 | 1994-05-26 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
| CN101252951B (en) | 2005-06-30 | 2011-12-21 | 森托科尔公司 | Anti-IL-23 antibodies, compositions, methods and uses |
| EA013506B1 (en) | 2005-08-25 | 2010-06-30 | Эли Лилли Энд Компани | Anti-il-23 antibodies |
| EP1931710B1 (en) | 2005-08-31 | 2017-01-18 | Merck Sharp & Dohme Corp. | Engineered anti-il-23 antibodies |
| HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-il-23 antibodies, compositions, methods and uses |
| PL2426144T3 (en) | 2007-02-23 | 2019-05-31 | Merck Sharp & Dohme | Engineered anti-il-23p19 antibodies |
| US8778346B2 (en) | 2010-11-04 | 2014-07-15 | Boehringer Ingelheim International Gmbh | Anti-IL-23 antibodies |
| AU2013256724A1 (en) * | 2012-05-03 | 2014-10-30 | Boehringer Ingelheim International Gmbh | Anti-IL-23p19 antibodies |
| WO2014004436A2 (en) * | 2012-06-27 | 2014-01-03 | Merck Sharp & Dohme Corp. | Crystalline anti-human il-23 antibodies |
| AU2014238148A1 (en) * | 2013-03-15 | 2015-10-08 | Amgen Inc. | Methods for treating psoriasis using an anti-IL-23 antibody |
| AU2016215535B2 (en) * | 2015-02-04 | 2021-09-16 | Boehringer Ingelheim International Gmbh | Methods of treating inflammatory diseases |
| JP7090014B2 (en) * | 2018-11-07 | 2022-06-23 | 株式会社ミツバ | How to manufacture rotors, motors, brushless wiper motors and rotors |
-
2016
- 2016-02-02 AU AU2016215535A patent/AU2016215535B2/en active Active
- 2016-02-02 CN CN201680008402.3A patent/CN107206081A/en active Pending
- 2016-02-02 EP EP16707997.9A patent/EP3253794A1/en active Pending
- 2016-02-02 MX MX2017010037A patent/MX2017010037A/en unknown
- 2016-02-02 KR KR1020177024896A patent/KR20170120616A/en not_active Application Discontinuation
- 2016-02-02 SG SG11201705728RA patent/SG11201705728RA/en unknown
- 2016-02-02 JP JP2017541030A patent/JP6758304B2/en active Active
- 2016-02-02 CN CN202110769475.7A patent/CN113559258A/en active Pending
- 2016-02-02 US US15/013,008 patent/US20160222102A1/en active Pending
- 2016-02-02 IL IL307578A patent/IL307578A/en unknown
- 2016-02-02 EA EA201791734A patent/EA201791734A1/en unknown
- 2016-02-02 SG SG10202103879YA patent/SG10202103879YA/en unknown
- 2016-02-02 CA CA2972995A patent/CA2972995A1/en active Pending
- 2016-02-02 BR BR112017014684A patent/BR112017014684A2/en active Search and Examination
- 2016-02-02 WO PCT/US2016/016061 patent/WO2016126638A1/en active Application Filing
-
2017
- 2017-06-22 IL IL253118A patent/IL253118A0/en unknown
- 2017-08-01 CL CL2017001960A patent/CL2017001960A1/en unknown
- 2017-08-01 PH PH12017501378A patent/PH12017501378A1/en unknown
- 2017-08-03 MX MX2022006573A patent/MX2022006573A/en unknown
- 2017-08-03 MX MX2022006575A patent/MX2022006575A/en unknown
-
2020
- 2020-04-27 JP JP2020078178A patent/JP7042297B2/en active Active
- 2020-04-27 JP JP2020078177A patent/JP7044824B2/en active Active
- 2020-04-27 JP JP2020078179A patent/JP7042298B2/en active Active
-
2021
- 2021-12-16 AU AU2021286378A patent/AU2021286378A1/en active Pending
-
2022
- 2022-03-17 JP JP2022042417A patent/JP2022081644A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL253118A0 (en) | 2017-08-31 |
| JP2022081644A (en) | 2022-05-31 |
| JP7042298B2 (en) | 2022-03-25 |
| CA2972995A1 (en) | 2016-08-11 |
| JP2018505882A (en) | 2018-03-01 |
| JP2020125339A (en) | 2020-08-20 |
| BR112017014684A2 (en) | 2018-01-09 |
| MX2022006575A (en) | 2022-07-11 |
| WO2016126638A1 (en) | 2016-08-11 |
| CL2017001960A1 (en) | 2018-04-20 |
| CN113559258A (en) | 2021-10-29 |
| MX2022006573A (en) | 2022-07-11 |
| EP3253794A1 (en) | 2017-12-13 |
| EA201791734A1 (en) | 2018-01-31 |
| AU2016215535A1 (en) | 2017-07-13 |
| JP7044824B2 (en) | 2022-03-30 |
| US20160222102A1 (en) | 2016-08-04 |
| JP2020125340A (en) | 2020-08-20 |
| AU2016215535B2 (en) | 2021-09-16 |
| KR20170120616A (en) | 2017-10-31 |
| PH12017501378A1 (en) | 2018-01-08 |
| JP6758304B2 (en) | 2020-09-23 |
| CN107206081A (en) | 2017-09-26 |
| AU2021286378A1 (en) | 2022-01-20 |
| IL307578A (en) | 2023-12-01 |
| MX2017010037A (en) | 2018-05-15 |
| JP2020125338A (en) | 2020-08-20 |
| SG10202103879YA (en) | 2021-05-28 |
| JP7042297B2 (en) | 2022-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266770A (en) | Methods of treating inflammatory conditions | |
| EP3359171C0 (en) | Use of akkermansia muciniphila for treating inflammatory conditions | |
| IL285151B1 (en) | Methods of treating fgf21-associated disorders | |
| IL253118A0 (en) | Methods of treating inflammatory diseases | |
| HK1246179A1 (en) | Methods of treating retinal diseases | |
| HK1252037A1 (en) | Methods of treating inflammatory diseases | |
| HK1248552A1 (en) | Method of treatment with tradipitant | |
| IL252296A0 (en) | Methods of treating multiple sclerosis | |
| IL249098A0 (en) | Methods and compositions for treating allergy and inflammatory diseases | |
| IL256207B (en) | Methods of treating multiple sclerosis | |
| HK1258994A1 (en) | Methods for treatment of diseases | |
| HK1247818A1 (en) | Method of treating diseases | |
| HK1244711A1 (en) | Treatment of hmgb1-mediated inflammation | |
| GB201416832D0 (en) | Methods of treatment | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| HK1249866A1 (en) | Methods of treatment with taselisib | |
| GB201515244D0 (en) | Treatment of inflammatory disease or condition | |
| HK1243937A1 (en) | Methods of treating diseases | |
| HK1246679A1 (en) | Treatment of filarial diseases | |
| GB201512139D0 (en) | Methods of treatment | |
| GB201516418D0 (en) | Treatment of acute inflammatory disorders | |
| GB201516140D0 (en) | Treatment of acute inflammatory disorders | |
| GB201521543D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513993D0 (en) | Methods for the treatment of inflammatory disorders | |
| GB201513345D0 (en) | Methods for the treatment of Inflammatory disorders |